Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Erythropoietin and Iron to Reduce Blood Transfusion in Cardiac Surgery
2012-002076-14Phase 4Active
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of epoetin alfa and ferric carboxymaltose in coronary arteriosclerosis and aortic valve disease (AVD) (2 arms). Primary endpoint: Mean number of transfused red blood cell units per patient. Started Jan 2014; status: active.
02
Drugs
epoetin alfaferric carboxymaltose
03
Conditions
coronary arteriosclerosisaortic valve disease (AVD)
Beyond the preview
Go deeper on 2012-002076-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002076-14.